Searching…
NRx is developing breakthrough medicines for people with life-threatening depression and PTSD. Our lead candidate, NRX-101, is the first oral medication in FDA trials for suicidal bipolar depression.
Organizations that use the NRX AssetHub platform and its module applications experience increased productivity, increased efficiencies, and cost savings in virtually all aspects of maintenance and operations.
Mar 4, 2024 · NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression.
We are NRx – a pioneering and focused CNS biopharma company, dedicated to meeting unmet medical needs for those with suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD).
Find the latest NRx Pharmaceuticals, Inc. (NRXP) stock quote, history, news and other vital information to help you with your stock trading and investing.
The NRX CMMS Services team can provide you with the specialized skills you need to implement, configure, and learn to use our solutions.
Jan 28, 2025 · NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal...
